(OMCL) at Deutsche Bank 41st Annual Health Care Conference

MOUNTAIN VIEW, Calif., April 29, 2016  — Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for health care facilities, today announced they will present at the Deutsche Bank 41^st annual Health Care Conference at the InterContinental Boston Hotel, Boston, MA.

Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Peter Kuipers, executive vice president & CFO

Date: Thursday, May 5, 2016
Time: 12:50 p.m. ET
Location: InterContinental Boston Hotel, Boston, MA
Availability: The audio-webcast of the live presentation may be accessed by visiting:
http://ir.omnicell.com/events.cfm

Following the conference, a replay of the audio-webcast will be archived for 90 days on the Omnicell website.

About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been creating innovative solutions to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire health care continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient’s home.

Over 4,000 customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.

The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. In addition, these solutions enable approximately 7,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit www.omnicell.com.